AI assistant
Sending…
Purple Biotech Ltd. — AGM Information 2016
Dec 6, 2016
7004_rns_2016-12-06_ec405e03-6aa5-4c61-a5e3-bec0375b0bb5.htm
AGM Information
Open in viewerOpens in your device viewer
_________ false
| ����� ����� ������ ��"� | 2 380 |
| KITOV PHARMACEUTICALS HOLDINGS LTD | |
| Corporation no: 520031238 | 10994 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 06/12/2016 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2016-02-137068 | Time of broadcast: 16:22 16:19:30 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Form 6-K: 2016 Annual Shareholders Meeting results |
| f6k120616_kitovpharmaEDGAR2_bannerless_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 31/10/2016 |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196 | |
| E-mail address: [email protected] Company site: www.kitovpharma.com | |
| Previous names of reporting entity: MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD, | |
| Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company: | |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132, Floor 23 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1 | |
| Israel |
More from Purple Biotech Ltd.
Report Publication Announcement
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
Apr 27
Report Publication Announcement
2026
Apr 27
Report Publication Announcement
2026
Apr 23
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 17
Director's Dealing
2026
Apr 17